These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2192020)

  • 1. Variations in the diagnosis, treatment, and prevention of cardiac allograft rejection: the need for standardization?
    O'Connell JB; Renlund DG
    J Heart Transplant; 1990; 9(3 Pt 2):269-71. PubMed ID: 2192020
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression following cardiac transplantation.
    Woodley SL; Renlund DG; O'Connell JB; Bristow MR
    Cardiol Clin; 1990 Feb; 8(1):83-96. PubMed ID: 2407363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 5. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
    Valantine H; Zuckermann A
    J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cardiac allograft rejection with intravenous corticosteroids.
    Miller LW
    J Heart Transplant; 1990; 9(3 Pt 2):283-7. PubMed ID: 2355284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of cardiac allograft rejection.
    O'Connell JB; Renlund DG
    Cardiovasc Clin; 1990; 20(2):147-62. PubMed ID: 2404596
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of cardiac transplant rejection.
    Woodley SL; Clayberger C
    Compr Ther; 1991 May; 17(5):32-8. PubMed ID: 1879125
    [No Abstract]   [Full Text] [Related]  

  • 12. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
    Kremer AB; Barnes L; Hirsch RL; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the diagnosis, treatment, and prevention of rejection in cardiac transplantation. Proceedings of a symposium of the International Society for Heart Transplantation. Colorado Springs, Colorado, July 28, 1989.
    J Heart Transplant; 1990; 9(3 Pt 2):269-320. PubMed ID: 2355281
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs.
    Crescioli C; Squecco R; Cosmi L; Sottili M; Gelmini S; Borgogni E; Sarchielli E; Scolletta S; Francini F; Annunziato F; Vannelli GB; Serio M
    Exp Cell Res; 2008 Apr; 314(6):1337-50. PubMed ID: 18291365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in cardiac transplantation.
    Mckenzie FN; Heimbecker RO
    Rinsho Kyobu Geka; 1982; 2(2):301-2. PubMed ID: 6760356
    [No Abstract]   [Full Text] [Related]  

  • 18. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH; Lucas BA; Amlot P; Janossy G; Yacoub M; Cammisuli S; Jezek D; Rhoades J; Brown S; Thompson JS
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin allotransplantation simultaneously with heart allotransplantation].
    Psillakis JM; Antonascio F; Décourt LV; Zerbini EJ; Sina V
    Rev Paul Med; 1971 Sep; 78(2):63-6. PubMed ID: 4152438
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of late allograft nephrectomy.
    Madore F; Hébert MJ; Leblanc M; Girard R; Bastien E; Morin M; Beaudry C; Boucher A; Dandavino R
    Clin Nephrol; 1995 Nov; 44(5):284-9. PubMed ID: 8605707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.